Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
P&G: Margin sacrifice led growth - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Apr 25, 2003

    P&G: Margin sacrifice led growth

    After a staid first half of FY03, P&G Hygiene & Healthcare Limited (P&G) has finally shown signs of strength in its March quarter numbers. The company has reported a strong 17% topline growth during this quarter. The company has compromised its operating margins (albeit marginally) to propel topline growth.

    (Rs m) 3QFY02 3QFY03 Change 9m FY02 9m FY03 Change
    Net Sales 816 956 17.1% 3,232 3,386 4.8%
    Other Income 19 36 90.0% 142 89 -37.4%
    Expenditure 637 755 18.6% 2,389 2,470 3.4%
    Operating Profit (EBDIT) 179 200 12.0% 843 916 8.6%
    Operating Profit Margin (%) 21.9% 21.0%   26.1% 27.0%  
    Interest 0 0 - 0 1 -
    Depreciation 37 25 -31.9% 158 87 -44.8%
    Profit before Tax 161 211 31.1% 826 916 10.9%
    Extraordinary items 0 -3 - 4 -16 -
    Tax 40 60 49.0% 208 237 14.0%
    Profit after Tax/(Loss) 121 148 22.4% 623 663 6.5%
    Net profit margin (%) 14.8% 15.5%   19.3% 19.6%  
    No. of Shares (eoy) (m) 21.6 21.6   21.6 21.6  
    Earnings per share* 22.3 27.3   38.4 40.9  
    Current P/e ratio   13.7     9.2  

    Aided by almost no interest burden and lower depreciation provisioning (down 32%), the company has managed to report over 22% bottomline growth, despite a 49% growth in tax provisioning. Depreciation provisioning has gone down as the company sold its Hyderabad factory assets to a contract manufacturer in January 2003.

    On a nine month basis, P&G has reported a 5% topline growth and a staid 7% bottomline growth. The significant dip in operating margins becomes apparent if one compares it against the 9mFY03 numbers (where OPM stood at 27%). It indicates that P&G has been forced to cut pricing of its products in a bid to sell more. And this seems to have worked for the company this quarter.

    as a % of sales 3QFY02 3QFY03 9m FY02 9m FY03
    Increase/(decrease) in stock in trade -6.7% -2.9% 0.7% 1.9%
    Raw material/packaging cost 30.6% 29.2% 29.2% 29.0%
    Raw material cost 11.9% 10.8% 7.5% 7.4%
    Staff cost 8.6% 9.9% 7.3% 8.1%
    Other expenses 33.8% 32.2% 29.2% 26.5%
    Total expenditure 78.1% 79.0% 73.9% 73.0%

    Sales of P&G's core categories, i.e., Health Care (Vicks) and Feminine Hygiene (Whisper) grew by 25% during the quarter, as compared to an overall 8% growth in 9mFY03. In 9mFY03 so far, Vicks has grown by 5% and Whisper business by 13%. The growth in Whisper has largely been spearheaded by Whisper Ultra.

    The company has recorded a significant growth in other income (90%) and this has propelled the bottomline in 3QFY03. We believe that P&G's sell off of its Hyderabad factory, for which P&G Singapore reimbursed the company, seems to have increased cash in the company, leading to higher other income. In the nine months comparision, other income for last year includes around Rs 73 m as extraordinary income, and therefore the dip in other income during 9mFY03.

    At the current price of Rs 375 the stock trades at a P/E of 9.2x 9mFY03 annualised earnings. The valuation is on the lower side of the FMCG spectrum. This is probably because of the company's two product focus, as well as concerns regarding the parent's other 100% subsidiaries.



    Equitymaster requests your view! Post a comment on "P&G: Margin sacrifice led growth". Click here!


    More Views on News

    P&G: Strong Core Growth (Quarterly Results Update - Detailed)

    Dec 9, 2016

    Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

    P&G: Strong Core Performance (Quarterly Results Update - Detailed)

    Oct 5, 2016

    Procter & Gamble Hygiene and Health Care reported a 0.1% YoY growth in sales and a 2.2% YoY increase in net profits during the quarter ended June 2016.

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    P&G: A Stable Quarter (Quarterly Results Update - Detailed)

    May 6, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 12% YoY during the quarter.

    P&G: Margins Go Through the Roof (Quarterly Results Update - Detailed)

    Feb 9, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 62% YoY during the quarter.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 18, 2017 (Close)


    • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks


    Compare Company With Charts